Neurocrine Biosciences (NBIX) Insider Trading & Ownership $119.85 -2.46 (-2.01%) (As of 09/18/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Neurocrine Biosciences (NASDAQ:NBIX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)17Amount OfInsider Selling(Last 12 Months)$80.25 M Get NBIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Neurocrine Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NBIX Insider Buying and Selling by Quarter Ad Crypto 101 MediaThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024. Go here to get full details on this crypto now. Neurocrine Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/15/2024William H RastetterDirectorSell14,250$146.69$2,090,332.50 8/13/2024Gary A LyonsDirectorSell11,570$150.43$1,740,475.10 8/13/2024Ingrid DelaetInsiderSell7,143$150.10$1,072,164.30 8/13/2024Matt AbernethyCFOSell14,100$150.38$2,120,358.00 8/6/2024Ingrid DelaetInsiderSell273$147.70$40,322.10 8/1/2024Julie CookeInsiderSell12,632$153.26$1,935,980.32 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/16/2024Gary A LyonsDirectorSell930$150.03$139,527.90 7/16/2024Julie CookeInsiderSell900$150.04$135,036.00 7/1/2024Julie CookeInsiderSell10,000$140.19$1,401,900.00 5/29/2024Stephen A SherwinDirectorSell40,000$133.46$5,338,400.00 5/17/2024Shalini SharpDirectorSell1,106$141.90$156,941.40 5/15/2024Matt AbernethyCFOSell15,000$140.24$2,103,600.00 5/14/2024Gary A LyonsDirectorSell12,500$135.63$1,695,375.00 5/6/2024Ingrid DelaetInsiderSell273$140.55$38,370.15 4/15/2024Eric BenevichInsiderSell19,818$133.36$2,642,928.48 3/21/2024Ingrid DelaetInsiderSell5,000$145.06$725,300.00 3/14/2024Eric BenevichInsiderSell75,000$139.38$10,453,500.00 3/14/2024George J. MorrowDirectorSell40,000$139.42$5,576,800.00 3/11/2024Ingrid DelaetInsiderSell200$140.00$28,000.00 3/11/2024Richard F PopsDirectorSell100$140.00$14,000.00 3/8/2024Ingrid DelaetInsiderSell1,800$140.03$252,054.00 3/8/2024Richard F PopsDirectorSell1,700$140.05$238,085.00 2/29/2024Ingrid DelaetInsiderSell273$135.51$36,994.23 2/27/2024Leslie V. NorwalkDirectorSell8,000$135.67$1,085,360.00 2/20/2024Richard F PopsDirectorSell15,000$132.47$1,987,050.00 2/13/2024Eiry RobertsInsiderSell1,114$132.96$148,117.44 2/13/2024Kevin Charles GormanCEOSell2,832$133.02$376,712.64 2/13/2024Matt AbernethyCFOSell1,352$132.85$179,613.20 2/8/2024David W BoyerInsiderSell1,328$135.41$179,824.48 2/8/2024Kevin Charles GormanCEOSell2,274$134.15$305,057.10 2/8/2024Matt AbernethyCFOSell980$134.21$131,525.80 2/6/2024David W BoyerInsiderSell456$141.96$64,733.76 2/6/2024Kevin Charles GormanCEOSell3,040$142.18$432,227.20 2/6/2024Matt AbernethyCFOSell1,280$142.19$182,003.20 1/31/2024Eiry RobertsInsiderSell1,457$140.79$205,131.03 1/31/2024Kevin Charles GormanCEOSell2,707$140.69$380,847.83 1/31/2024Matt AbernethyCFOSell1,283$140.72$180,543.76 1/22/2024Darin LippoldtInsiderSell10,000$139.86$1,398,600.00 1/8/2024Kevin Charles GormanCEOSell105,835$132.44$14,016,787.40 1/2/2024Kyle GanoInsiderSell75,000$131.47$9,860,250.00 This Crypto Is Set to Explode in September (Ad)With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make HUGE gains. Now, I'm about to reveal the #1 crypto for September 2024. Go here to get full details on this crypto now. 1/2/2024William H RastetterDirectorSell11,044$131.47$1,451,954.68 12/22/2023Eiry RobertsInsiderSell10,000$126.74$1,267,400.00 12/12/2023Eiry RobertsInsiderSell13,925$120.30$1,675,177.50 12/8/2023Eiry RobertsInsiderSell300$120.10$36,030.00 12/6/2023Darin LippoldtInsiderSell20,830$119.86$2,496,683.80 12/1/2023Gary A LyonsDirectorSell5,000$116.77$583,850.00 11/29/2023Jude OnyiaInsiderSell2,331$113.57$264,731.67 11/27/2023Darin LippoldtInsiderSell10,919$112.27$1,225,876.13 10/2/2023David W BoyerInsiderSell1,437$112.68$161,921.16 (Data available from 1/1/2013 forward) NBIX Insider Trading Activity - Frequently Asked Questions Who is on Neurocrine Biosciences's Insider Roster? The list of insiders at Neurocrine Biosciences includes Darin Lippoldt, David W Boyer, Dimitri E Grigoriadis, Eiry Roberts, Eric Benevich, Gary A Lyons, George J. Morrow, Ingrid Delaet, Jude Onyia, Julie Cooke, Kevin Charles Gorman, Kyle Gano, Leslie V. Norwalk, Malcolm Lloyd-Smith, Matt Abernethy, Neurocrine Biosciences Inc, Richard F Pops, Shalini Sharp, Stephen A Sherwin, and William H Rastetter. Learn more on insiders at NBIX. What percentage of Neurocrine Biosciences stock is owned by insiders? 4.30% of Neurocrine Biosciences stock is owned by insiders. Learn more on NBIX's insider holdings. Which Neurocrine Biosciences insiders have been buying company stock? The following insider purchased NBIX shares in the last 24 months: Neurocrine Biosciences Inc ($39,032,821.44). How much insider buying is happening at Neurocrine Biosciences? Insiders have purchased a total of 4,395,588 NBIX shares in the last 24 months for a total of $39,032,821.44 bought. Which Neurocrine Biosciences insiders have been selling company stock? The following insiders have sold NBIX shares in the last 24 months: Darin Lippoldt ($7,453,242.21), David W Boyer ($853,720.03), Eiry Roberts ($4,982,223.40), Eric Benevich ($23,323,116.37), Gary A Lyons ($7,558,728.00), George J. Morrow ($5,576,800.00), Ingrid Delaet ($2,347,065.90), Jude Onyia ($608,100.93), Julie Cooke ($4,748,356.97), Kevin Charles Gorman ($17,369,891.33), Kyle Gano ($9,860,250.00), Leslie V. Norwalk ($1,085,360.00), Matt Abernethy ($7,963,690.98), Richard F Pops ($2,239,135.00), Shalini Sharp ($156,941.40), Stephen A Sherwin ($8,904,200.00), and William H Rastetter ($4,707,062.54). How much insider selling is happening at Neurocrine Biosciences? Insiders have sold a total of 851,252 Neurocrine Biosciences shares in the last 24 months for a total of $109,737,885.06 sold. More Insider Trading Tools from MarketBeat Related Companies: Bio-Techne Insider Buying CRISPR Therapeutics Insider Buying Denali Therapeutics Insider Buying Adaptive Biotechnologies Insider Buying Alnylam Pharmaceuticals Insider Buying Biogen Insider Buying BioMarin Pharmaceutical Insider Buying United Therapeutics Insider Buying Incyte Insider Buying Exact Sciences Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:NBIX) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurocrine Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurocrine Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
